Under pressure from Trump, Pfizer cuts prices on some drugs in the US
Tomas Kauer - - News Moderator 
Yielding to demands from Washington, the pharmaceutical company agreed to lower the price of medications available under public health insurance program Medicaid in exchange for a three-year exemption from tariffs.
